SCHEMBL7229028

SCHEMBL7229028

CC(=O)c1ccccc1NC(=O)/C=C/c1ccc(-c2nc3c([nH]2)c(=O)n(CC2CCCCC2)c(=O)n3CC2CCCCC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 15/20 0.74
▸ ADORA3 P0DMS8 8/20 0.74
▸ ADORA1 P30542 10/20 0.70
▸ ADORA2A P29274 9/20 0.70
▸ CYP3A4 P08684 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7229037 1.00 ADORA2B (0.74) ADORA2BADORA3ADORA1ADORA2ACYP3A4
SCHEMBL7220060 0.85 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2ACYP3A4
SCHEMBL7220057 0.85 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2ACYP3A4
SCHEMBL7228404 0.83 ADORA2B (0.79) ADORA2BADORA3ADORA1ADORA2ACYP3A4
SCHEMBL7228400 0.83 ADORA2B (0.79) ADORA2BADORA3ADORA1ADORA2ACYP3A4
SCHEMBL28457457 0.80 ADORA2B (0.69) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL6554039 0.72 ADORA2B (0.62) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL6554035 0.72 ADORA2B (0.62) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL7783053 0.71 ADORA2B (0.57) ADORA2BADORA3ADORA1ADORA2AALDH1A1
Ethylene SCHEMBL6745653 0.70 ADORA2B (0.74) ADORA2BADORA3ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545002-B1 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2003-04-08 — — US disclosed
Send feedback